Overview
What is Ohio Hematopoietic Transplant And Cellular Therapy Consortium?
The Ohio Hematopoietic Transplant and Cellular Therapy Consortium is a nonprofit organization, specifically located at 5400 Port Haven Drive, Galena, Ohio 43021. Their primary mission is to ensure all Ohio residents have access to top-notch care for hematologic malignancies. They achieve this by identifying eligible patients based on specific criteria and clinical summaries, providing access information, and maintaining a statewide waiting list. Their activities are geared towards guaranteeing all Ohioans receive high-quality care for hematologic diseases.
Is Ohio Hematopoietic Transplant And Cellular Therapy Consortium legitimate?
Ohio Hematopoietic Transplant And Cellular Therapy Consortium is a legitimate nonprofit organization registered as a 501(c)(3) entity. Ohio Hematopoietic Transplant And Cellular Therapy Consortium submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $0
For more financial information, click here
What is the mission statement of Ohio Hematopoietic Transplant And Cellular Therapy Consortium?
The Ohio Hematopoietic Transplant and Cellular Therapy Consortium is committed to ensuring that all residents in Ohio have access to high-quality care for hematologic malignancies. To achieve this, they identify suitable patients for transplant based on specific selection criteria and clinical summaries. They also provide information on access and maintain a statewide waiting list, ensuring equitable care for individuals in need.
Who is the CEO of Ohio Hematopoietic Transplant And Cellular Therapy Consortium?
Matt Kalay is the Principal Officer of Ohio Hematopoietic Transplant And Cellular Therapy Consortium.
What is the revenue of Ohio Hematopoietic Transplant And Cellular Therapy Consortium?
Ohio Hematopoietic Transplant And Cellular Therapy Consortium's revenue in 2022 was $105,149.
Who are the executives of Ohio Hematopoietic Transplant And Cellular Therapy Consortium and what are their salaries?
Here are 5 key members and their salaries:
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
Where can I find the form 990 for Ohio Hematopoietic Transplant And Cellular Therapy Consortium?
Ohio Hematopoietic Transplant And Cellular Therapy Consortium's most recent form 990 was submitted in 2022 and can be accessed here.
Mission Statement of Ohio Hematopoietic Transplant And Cellular Therapy Consortium
The Ohio Hematopoietic Transplant and Cellular Therapy Consortium is committed to ensuring that all Ohio residents have access to high-quality care for hematologic malignancies. This nonprofit organization works diligently to achieve this mission by identifying eligible patients based on specific selection criteria and clinical summaries. Furthermore, the Consortium provides access information and maintains a statewide waiting list, ensuring that patients in need can access the necessary care efficiently. By doing so, the Ohio Hematopoietic Transplant and Cellular Therapy Consortium plays a crucial role in improving the lives of Ohio residents living with hematologic malignancies.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
The Ohio Hematopoietic Transplant and Cellular Therapy Consortium significantly enhances patient care for those facing hematologic malignancies. By establishing a structured approach to identify patients eligible for transplant, it streamlines access to potentially life-saving treatments. The consortium prioritizes patient selection through well-defined criteria and comprehensive clinical summaries, ensuring that individuals receive tailored care suited to their specific conditions.
Furthermore, it provides crucial access information for patients and families navigating complex medical systems and maintains a state-wide waiting list. This transparency and organization not only optimize resource allocation but also promote equality in access to treatment across Ohio. Ultimately, the consortium plays a pivotal role in improving health outcomes and quality of life for residents dealing with serious blood-related illnesses.
This information is meant to be a general summary of Ohio Hematopoietic Transplant And Cellular Therapy Consortium. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Investment Income: $55
- Gross Receipts: $105,149
Assets and Liabilities:
- Total Assets: $330,785
- Total Liabilities: $110,578
- Net Assets: $220,207
Want to help this charity, for free? You can click here to learn more about Give Freely
Organization Details
Founding Year
1992
Phone
(216) 444-9100Principal Officer
Matt Kalay
Main Address
5400 PORT HAVEN DRIVE, GALENA, OH, 43021
NTEE Category
Code: G30Z - Disease
If you are a representative of Ohio Hematopoietic Transplant And Cellular Therapy Consortium and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.